selegiline has been researched along with AIDS Dementia Complex in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, C; Clifford, DB; Ernst, T; Marra, CM; Nath, A; Navia, BA; Sacktor, N; Schifitto, G; Yiannoutsos, CT | 1 |
| Jordan-Sciutto, KL; Kolson, DL; Lindl, KA; Marks, DR | 1 |
| Chauhan, A; Chen, KC; Conant, K; Cutler, R; Gairola, C; Gartner, S; Haughey, N; Hauser, KF; Jie, C; Liu, Y; Mattson, MP; McArthur, JC; Nath, A; Pardo, C; Peng, X; Reid, R; Sacktor, N; Turchan-Cholewo, J | 1 |
| Clifford, DB; Ellis, RJ; Evans, SR; Hung, VL; Katzenstein, D; Kolson, D; Marra, CM; Millar, LL; Miller, EN; Remmel, R; Sacktor, N; Schifitto, G; Simpson, D; Singer, E; Smith, E; Valcour, V; Weihe, J; Zhang, J | 1 |
| Brew, BJ | 1 |
| Demuth, M; Götz, ME; Koutsilieri, E; Riederer, P; Sauer, U; Sopper, S; ter Meulen, V | 1 |
| Czub, M; Czub, S; Gerlach, M; Gosztonyi, G; Gsell, W; Heeney, JL; Koutsilieri, E; Müller, JG; Pedersen, V; Riederer, P; Sopper, S; Stahl-Hennig, C; ter Meulen, V | 1 |
1 review(s) available for selegiline and AIDS Dementia Complex
| Article | Year |
|---|---|
HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.
Topics: AIDS Dementia Complex; Animals; Anti-HIV Agents; Brain; HIV-1; Humans; Memantine; Minocycline; Neuroimmunomodulation; Selegiline | 2010 |
2 trial(s) available for selegiline and AIDS Dementia Complex
| Article | Year |
|---|---|
Selegiline and oxidative stress in HIV-associated cognitive impairment.
Topics: Adult; AIDS Dementia Complex; Biomarkers, Pharmacological; Cognition Disorders; Female; HIV Infections; Humans; Male; Middle Aged; Oxidative Stress; Selegiline | 2009 |
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.
Topics: Adult; Aged; AIDS Dementia Complex; Antioxidants; Brain; Cytoprotection; Female; Humans; Male; Middle Aged; Nerve Degeneration; Neuroprotective Agents; Neuropsychological Tests; Placebos; Selegiline; Treatment Failure | 2007 |
4 other study(ies) available for selegiline and AIDS Dementia Complex
| Article | Year |
|---|---|
Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.
Topics: Adult; AIDS Dementia Complex; Antioxidants; Apolipoprotein E4; Apolipoproteins E; Cells, Cultured; Coculture Techniques; Diosgenin; Gene Expression; Gene Products, tat; Genetic Predisposition to Disease; HIV; HIV Envelope Protein gp120; HIV Infections; Humans; Male; Membrane Potentials; Mitochondria; Morphine; Narcotics; Neurons; Neuroprotective Agents; Neurotoxins; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Polymerase Chain Reaction; Reactive Oxygen Species; Selegiline; tat Gene Products, Human Immunodeficiency Virus; Viral Proteins | 2006 |
Lost in translation: again, another failed neuroprotection trial.
Topics: AIDS Dementia Complex; Antioxidants; Biomarkers; Clinical Trials as Topic; Cytoprotection; Dose-Response Relationship, Drug; Humans; Nerve Degeneration; Nerve Growth Factors; Neuroprotective Agents; Oxidative Stress; Selegiline; Treatment Failure | 2007 |
Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro.
Topics: AIDS Dementia Complex; Carrier Proteins; Cell Survival; Cells, Cultured; Cocaine; Disease Progression; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Glutathione; HIV-1; Humans; Macrophages; Membrane Glycoproteins; Membrane Transport Proteins; Morphine; Narcotics; Nerve Tissue Proteins; Oxidative Stress; Selegiline; Substance-Related Disorders; Tumor Cells, Cultured; Up-Regulation | 1997 |
Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs.
Topics: AIDS Dementia Complex; Animals; Central Nervous System; Dendrites; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Encephalitis, Viral; Macaca mulatta; Neuroprotective Agents; Selegiline; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Vacuoles; Virus Replication | 2001 |